Stock XLSCF XLIE SCIE
Add to a list
To use this feature you must be a member
Log inSign up

All News XLIE SCIE OTC Markets

Equities

XLSCF

CH0461929603

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for XLIE SCIE -.--% -.--%
04-23 Xlife Sciences Posts Higher FY23 Profit; Revenue Falls MT
02-29 Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Xlife Sciences : Valuation Report 2023
PU
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
EQ
Xlife Sciences Posts Higher FY23 Profit; Revenue Falls
MT
Xlife Sciences AG Publishes 2023 Annual Report
EQ
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
EQ
Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Switzerland’s Xlife Sciences, Abu Dhabi Expand Existing Life Sciences Partnership
MT
Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City
EQ
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
EQ
Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases
EQ
Xlife Sciences, Quant Team Up to Develop Biomarkers for Kidney Diseases Detection
MT
Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases
EQ
Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration
EQ
Xlife Sciences to Sell Portfolio Company to 4D Lifetec
MT
Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million
EQ
Xlife Sciences AG acquired 20% stake in 4D Lifetec AG for CHF 23.3 million.
CI
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023
EQ
Xlife Sciences Loss Narrows in H1; Revenue Declines
MT
Xlife Sciences with significant progress in H1 2023
EQ
Xlife Sciences AG Reports Earnings Results for the Half Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XLS Stock
  4. XLSCF Stock
  5. News XLIE SCIE